Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Odfjell SE: Approval of base prospectus and change of ISIN

The Financial Supervisory Authority of Norway has on May 11, 2022, approved Odfjell SE’s Registration Document and a Securities Note, both dated May 11, 2022.The Registration Document and Securities Note were prepared in connection with the listing on the Oslo Stock Exchange of the Odfjell SE FRN senior unsecured NOK 275,000,000 bond tap issue dated November 19, 2021 with temporary ISIN NO0011154676. The Registration Document and Securities Note are available at Odfjell.com. The bond issue with temporary ISIN NO0011154676 will be merged with the bond issue with original ISIN

Klaria Interim Report Q1 2022

Klaria Interim Report Q1 2022Summary of the Interim Report First quarter of 2022 - Net sales amounted to 0.0 MSEK (0.0 MSEK) - R&D costs for the period amounted to 17.1 MSEK (11.4 MSEK) - Profit after tax amounted to -20.3 MSEK (-16.7 MSEK) - Earnings per share for the quarter amounted to -0.37 SEK (0.32 SEK) - Cash flow from operating activities amounted to -19.8 MSEK (17.1 MSEK) - Cash and cash equivalents on the balance sheet date amounted to 23.0 MSEK (48.2 MSEK) - Equity as of March 31 amounted to 72.1 MSEK (126.3 MSEK) - Pursuant to the authorization granted

Concentric AB transfer own shares

The participants in LTI 2019 have the right to receive 99,184 shares, but as the performance-based terms have not been met, 49,592 shares will be transferred. In accordance with the terms of LTI 2019, 24,796 shares have a purchase price for the participants of SEK 114.00 and 24,796 shares have a purchase price of SEK 171.00. Under the authorisation from the annual general meeting 2022, the board of Concentric has resolved to sell a maximum of 49,592 shares on Nasdaq Stockholm. The difference between the sale price and the purchase price in the terms of LTI 2019 will be paid to the

Kent NHS trusts in the UK to modernize patient diagnostics with Sectra in a multi-hospital collaborative environment

Linköping, Sweden – May 12, 2022 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has signed a contract with Kent and Medway Medical Imaging Consortium. The new agreement will help a consortium of trusts deliver faster diagnoses, improve capacity and deliver community diagnostics. Benefits from utilizing the same imaging system as many other trusts across large of South East England are also expected.Sue Lang, who has worked as program lead for the consortium and radiology transformation program manager for East Kent Hospitals

Raisio plc: Managers´ transactions

Raisio plc Managers´ transactions 12 May 2022   MANAGERS’ TRANSACTIONS   Person subject to the notification requirement Name: Pekka Kuusniemi Position: Chief Executive Officer Issuer: Raisio Oyj LEI: 74370083282NHIP4QD02   Notification type: INITIAL NOTIFICATION Reference number: 14778/5/6 ____________________________________________   Transaction date: 2022-05-11 Venue: EUCC Instrument type: SHARE ISIN: FI0009002943 Nature of the transaction: ACQUISITION   Transaction details (1): Volume: 5911 Unit price: 1.992 EUR

3 new companies to present at the BioStock Life Science Spring Summit on June 8-9!

On June 8-9, it is finally time for BioStock Life Science Spring Summit 2022, where companies from a wide range of therapeutic areas will present their projects and innovations, in a packed program that also offers valuable insights from investment experts and industry profiles. Today, we reveal three new companies that will present at the Spring Summit!The event will be broadcasted on the BioStock website and on our YouTube channel. You can also access the event through our social media platforms. Today, we reveal three new companies that will present at the BioStock Life Science Spring

Interim Report for 1st Quarter 2022

Q1 2022 - Challenging Quarter, Improved Start of Q2 2022Key Facts for the 1[st] Quarter 2022 (1[st] January 2022 – 31[st] March 2022) All figures are compared to the same quarter last year if not explicitly stated otherwise · Revenues decreased by 41.92% to € 7,848,997 (€13,515,110). · EBIT decreased by 88.96% to € 417,239 (€3,779,057). · EBIT margin of 5.32% (27.96%). · Customer deposits decreased by 35.97% to €17,236,925 (€26,918,069).  · 74,751 new registered customers (71,709), increase of 4.24%. · 13,185 new depositing customers (29,813), decrease of 55.77%. ·

Isofol Medical AB (publ) publishes interim report, January–March 2022

GOTHENBURG, Sweden, May 12, 2022 - Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL), announced today that the company's interim report for January–March 2022 is now available on the company's website, www.isofolmedical.com .First quarter, January–March 2022 · Net revenue amounted to TSEK 4,006 (5,215) and other revenue to TSEK 1 (0) · The result for the period amounted to TSEK -47,874 (-42,662) · Earnings per share amounted to SEK -0.30 (-0.51) · Cash and cash equivalents on March 31 amounted to TSEK 332,035 (77,524)

Intelligent instruments for optimizing mining operations: introducing Metso Outotec Sense series

Metso Outotec Corporation’s press release on May 12, 2022, at 09:00 a.m. EESTMetso Outotec has grouped its portfolio of intelligent instruments under the Sense series. The portfolio is designed to solve specific process challenges and enable optimization for minerals and hydrometallurgical processes. The market’s most comprehensive portfolio of intelligent instruments is part of Metso Outotec’s Planet Positive offering. Covering the entire flowsheet, Sense series instruments are suited for both new and existing operations. “Metso Outotec Sense series includes specialized instruments that

Fractal Gaming Group Interim Report January-March 2022

First quarter 2022 · Net sales amounted to SEK 117.5 million (169.1). · Product profit amounted to SEK 47.2 million (58.8), with a product margin of 40.2% (34.8). · EBITDA amounted to SEK 11.3 million (10.6), corresponding to an EBITDA margin of 9.6% (6.3). · EBIT amounted to SEK 7.3 million (7.6), corresponding to an EBIT margin of 6.2% (4.5). · No items affecting comparability during the first quarter of 2022. The first quarter of 2021 included items affecting comparability of SEK 21.1 million, which were entirely related to costs for the IPO. · Operating cash flow

Peab builds the block Gladan in Gällivare

Peab has been commissioned to build the new block Gladan with 85 rental apartments, a parking garage and commercial space in central Gällivare. The customer is LKAB and the contract is worth SEK 349 million.The block is centrally located just off Lasarett Street. The block containing apartments and a parking garage will replace parts of TopBostäder AB’s apartment buildings in Malmberget. The project comprises planning and construction of a total of 85 apartments in Gladan 3 and 7 along with a parking garage and commercial space. Gladan 1 will consist of parking for city center commerce.

Fuud publishes interim report Jan – March 2022

STOCKHOLM, May 12, 2022 08.00 CETFinancial information for the period January-March 2022* · Net sales for the period amounted to SEK 22,117 thousand (218). Previous period the net sales amounted to SEK 18,608 thousand, which means a growth of + 19% · Operating profit amounted to SEK -23,158 thousand (-3,974). During the previous quarter, operating profit amounted to SEK -29,275 thousand, excluding write-downs of goodwill. An improvement corresponding to 20.9%. · Operating profit/loss for the period before depreciation amounted to SEK -15,485 thousand (-3,910). Improvement of + 29.

SLP certifies its first properties according to Miljöbyggnad iDrift

SLP has certified its first properties under the Sweden Green Building Council’s (“SGBC”) Miljöbyggnad iDrift (Environmental Building in Use) scheme. The certification is an important part of SLP’s efforts to create sustainable management of existing properties.Today, SLP has obtained certification for Miljöbyggnad iDrift level Silver for two of the company’s properties in Malmö, Ventilen 5 and Segeholm 10. SLP’s head office is located in the Segeholm 10 property, which has been modernised with the installation of modern LED lighting and a new ventilation system. Ventilen 5 was extended in

Waystream delivers access switches to an additional eight municipalities in Sweden

Press release May 12, 2022 Waystream 's partner NetNordic  Sweden has signed a multi-year framework agreement with Kurbit , which is Dalarna's largest communications operator, and a joint venture for five city network companies in Dalarna and eight Dalarna municipalities*. The agreement pertains to Kurbit’s intention to replace its existing access equipment, which includes 50 000 customer connections, to Waystream's switches.“Many people feel compelled to predict the future; however, few get it right, and it is

Fastighets AB Balder Interim report January-March 2022

· Profit from property management attributable to parent company shareholders amounted to SEK 1,382m (1,088), corresponding to an increase per share by 27 % to SEK 7.41 (5.83) · Long term net asset value amounted to SEK 540.24 per share (405.27) · Rental income amounted to SEK 2,507m (2,118) · Profit after tax attributable to parent company shareholders amounted to SEK 5,261m (2,665) corresponding to SEK 28.21 per share (14.29) Profit from property management for the period amounted to SEK 1,521m (1,228). Profit from property management attributable to parent company

Interim report

January 1 – March 31, 2022The first quarter in figures · Net sales amounted to TSEK 4,260 (2,562). · The loss after tax amounted to TSEK 9,736 (8,153). · The loss per share amounted to SEK 0.14 (0.15). · The cash flow from current operations was negative in the amount of TSEK 10,512 (9,473). · The gross margin reached 62.8% (52.7%). · Electrode sales volume increased by 33% and reached 9,982 (7,496) units. Repeat sales of electrodes to existing customers increased by 34%. Important events during the quarter · Overall sales increased by 66% (+58%, before currency

Nordstjernan issues call options in Alligo

The chairman of the board of Alligo AB (publ), Göran Näsholm, has acquired call options for shares in Alligo. The call options were issued on market-based terms by Alligo’s principal owner, Nordstjernan AB. The call options do not entail any dilution for the other shareholders. Alligo is not participating in the issue of the call options and will not be charged with any related costs.Peter HofvenstamPresident and CEONordstjernan ABQuestions will be answered by:Peter Hofvenstam, CEO, NordstjernanE-mail: peter.hofvenstam@nordstjernan.seStefan Stern, Head of Communications,

Relais Group Plc Interim Management Statement 1 January–31 March 2022 (unaudited) – Moving forward on the growth path

Relais Group PlcCompany release 12 May 2022, 9:00 a.m. EET This release is a summary of Relais Group's Interim Management Statement January-March 2022. The full release is attached to this company release and is available on our website at https://relais.fi/en/investors/. JANUARY–MARCH 2022 IN BRIEF · Net sales totaled EUR 61.9 million (January–March 2021: 53.5), +15.7% change · EBITDA was EUR 6.6 (7.6) million, 10.7% (14.3%) of net sales, -13.6% change · EBITA was EUR 6.1 (7.4) million, 9.9% (13.8%) of net sales, -17.4% change · EBIT was EUR 2.5 (4.6) million, 4.1% (8.

Last day of trading in paid subscribed shares (Sw. betalda tecknade aktier) in SynAct Pharma AB

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. PLEASE REFER TO “IMPORTANT INFORMATION” AT THE END OF THE PRESS RELEASE. Today, SynAct Pharma AB (“SynAct” or the “Company”) announces that the preferential rights issue of shares that was resolved upon by the board of directors on 28 March

Prostatype Genomics presents Quarterly Report

Prostatype Genomics AB has today published its quarterly report for the first quarter comprising the period from 1 January 2022 to 31 March 2022. The report is available on the company website.Quarter 1 (1 March – 31 March 2022) summarized · Net sales amounted to 264 TSEK. · Net revenue amounted to 260 TSEK. · EBITDA (earnings before interest, taxes, depreciation, and amortization) amounted to – 5 050 TSEK. · Cash flow from current operations in the quarter amounted -5 802 TSEK. · Total cash flow for the period amounted to -5 903 TSEK. · Earnings per share amounted to -0,

Irisity AB (publ) delivers a good start to the year with continued strong growth.

The CEO comments on the first quarter: Irisity's net sales increased 42% on an organic basis and by 165% to SEK 30 M (11.3) including acquisitions. The gross margin was strengthened to 77,0 percent (72,8) and the monthly recurring income (MRR) was SEK 7.0 million. EBITDA amounted to SEK -4.8 million (-0.5) in the quarter and has been charged by pilot installations. Net income has been burdened by amortization of goodwill and intangible assets. The cash position follows plan. Through continued building of the sales force and our international market presence, as well as through

There are no items matching the current filter
There are no more items matching the current filter
Back to top